The new report by Expert Market Research titled, ‘Global Oligonucleotide Synthesis Market Trends, Size, Share, Growth, Analysis, Report and Forecast 2023-2028’, gives an in-depth analysis of the global oligonucleotide synthesis market, assessing the market based on its segments like product, application, end-use, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
The key highlights of the report include:
Market Overview (2018-2028)
- Forecast CAGR (2023-2028): 13.1%
North America was a major geographic market for oligonucleotide synthesis in the past, and it is projected to remain so in the future. The market for oligonucleotide synthesis has been catalysed by the growing importance of life sciences research and development, which can be attributed to this region’s increased focus on improving the safety and quality of healthcare, the growing demand for high-quality research tools for data reproducibility, and the growing focus on developing personalised therapeutics.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/oligonucleotide-synthesis-market/requestsample
In the future years, the oligonucleotide synthesis sector in the Asia Pacific is predicted to increase at a healthy rate. Some of the primary drivers supporting the expansion of the oligonucleotides synthesis business in the Asia Pacific area include the expanding availability of synthesised oligonucleotides, the strong presence of pharma and biotech enterprises, and the growing research outsourcing to CROs.
The presence of improved healthcare infrastructure, increased use of oligonucleotides by regional pharmaceutical businesses, and numerous strategic alliances among the market’s main players are projected to propel the oligonucleotide synthesis industry forward in the region.
Oligonucleotide Synthesis Industry Definition and Major Segments
Single-stranded DNA fragments that have been chemically synthesised into short segments are known as synthetic oligonucleotides. The approach is particularly beneficial in the lab since it allows researchers to obtain custom-made oligonucleotides of the appropriate sequence quickly and at a low cost.
It can also be used for molecular diagnosis in a variety of disorders, including the identification of infectious diseases like hepatitis and SARS-COV2, as well as a cancer diagnosis.
Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/oligonucleotide-synthesis-market
By product, the market can be segmented into:
- Breakup by type:
- Column-Based Oligos
- Array-Based Oligos
- Breakup by Nucleic Acid Type
- DNA Oligos
- RNA Oligos
- Breakup by type:
- Based on type:
- Oligo Synthesis
- Based on quantity:
- 25 nmol
- 50 nmol
- 200 nmol
- 1,000 nmol
- 10,000 nmol
- Based on type:
Based on application, the oligonucleotide synthesis industry is segmented into:
- PCR Primers
- PCR Assays-Panels
- DNA Microarrays
- Fluorescence in Situ Hybridisation (FISH)
- Antisense Oligonucleotides
On the basis of end use, the market is classified into:
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical–Biotechnology Companies
The regional markets for oligonucleotide synthesis can be divided into:
- North America
- the Asia Pacific
- Latin America
- the Middle East and Africa
Oligonucleotide Synthesis Market Trends
One of the factors driving the market’s growth is an increase in research and development spending by pharmaceutical and biotechnology companies to develop oligonucleotide products with greater therapeutic potential and fewer adverse effects.
The market is likely to grow even faster as government financing for synthetic biology and genome projects grows, as well as through rigorous research. Government investments have boosted the development of new technology significantly. Increased investment and development in these sectors are projected to fuel oligonucleotide synthesis market growth.
These ongoing, government-funded studies are expected to advance genomic technologies such as DNA sequencing, DNA amplification, next-generation sequencing (NGS), and gene expression.
Growing demand for high-end tailored oligonucleotides and improvements in the purification of synthetic oligonucleotides are also helping the oligonucleotide synthesis industry’s growth. In recent years, major players have been acquiring different small-scale oligonucleotide synthesis companies to widen their product and service offerings and expand their footprint in the oligonucleotide synthesis sector, which has aided market growth.
Advances in enzyme failure repair technology have also reduced the occurrence of synthesis faults, which is projected to boost market expansion in the coming years.
Key Market Players
The major players in the market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Merck KGaA, Agilent Technologies, Inc., Bio-Synthesis Inc., and LGC Biosearch Technologies.
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Read More Reports :
United States Smart Thermostat Market: https://www.expertmarketresearch.com/reports/united-states-smart-thermostat-market
United States Dialysis Services Market: https://www.expertmarketresearch.com/reports/united-states-dialysis-services-market
Global Video Laryngoscope Market: https://www.expertmarketresearch.com/reports/video-laryngoscope-market
Global Space Propulsion Systems Market: https://www.expertmarketresearch.com/reports/space-propulsion-systems-market
Global Server Operating System Market: https://www.expertmarketresearch.com/reports/server-operating-system-market
About Us :
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact :
Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gloud Street, Sheridan, WY 82801, USA